Next-Generation Cancer Diagnostics: AI-Integrated Blood Marker Liquid Biopsy

Abstract

Adding AI technology to liquid biopsy offers new and better methods to detect and 
monitor cancer. A non-invasive blood test named liquid biopsy reveals promising 
possibilities for finding cancer early and watching its development to design 
personal treatment. Patients benefit from AI technology when it helps liquid 
biopsy identify better cancer indicators early and track their overall health status 
in real-time. Modern systems discover cancer gene problems plus discovers 
tumour signs while precisely tracing all disease spots. AI upgrades help liquid 
biopsy systems change cancer treatment by allowing doctors to find diseases soon 
and design better treatment plans for patients. The enhanced methods identify 
mutations linked to cancer plus tumor indicators and minor disease traces which 
regular systems cannot catch. With AI-enhanced liquid biopsy we can make faster 
cancer diagnosis followed by more targeted therapy designs while monitoring 
patient results better. This paper describes new developments while showing how 
AI makes liquid biopsy testing better for medical oncology patients.